Intermittent nesiritide therapy in outpatients with chronic heart failure
Heart failure (HF) continues to be a significant health problem in the United States. Nearly 550,000 people are diagnosed annually with this condition, and HF is responsible for over 1 million hospitalizations per year.1,2 Despite advances in pharmacologic therapy, a small percentage of patients wit...
Saved in:
| Main Author: | Sheikh-Taha, Marwan (author) |
|---|---|
| Format: | article |
| Published: |
2005
|
| Online Access: | http://hdl.handle.net/10725/3932 https://doi.org/10.1093/ajhp/62.2.196 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://academic.oup.com/ajhp/article-abstract/62/2/196/5135612 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacy of six-month outpatient intermittent nesiritide infusions
by: Sheikh-Taha, Marwan
Published: (2011) -
Effect of Intermittent Nesiritide Administration on Kidney Function
by: Sheikh-Taha, Marwan
Published: (2012) -
The Safety of Novel Therapies in Chronic Lymphocytic Leukemia in the Era of Intermittent Fasting: A Pharmacology-Based Review
by: Maria Benkhadra (19756941)
Published: (2024) -
Revisiting Beta-Blocker Therapy in Heart Failure with Preserved Ejection Fraction
by: Rasha Kaddoura (12506936)
Published: (2023) -
Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications
by: Ramia, Elsy
Published: (2014)